187 related articles for article (PubMed ID: 22097237)
1. Liver metastasis from colonic adenocarcinoma presenting as nephrolithiasis: computed tomography findings.
Abu-Ghanem S; Novik EF; Abu-Ghanem Y; Man S; Shelef I
Isr Med Assoc J; 2011 Oct; 13(10):638-9. PubMed ID: 22097237
[No Abstract] [Full Text] [Related]
2. [Rapidly Growing Interval Colon Cancer].
Kim JH; Park MI
Korean J Gastroenterol; 2015 May; 65(5):326-9. PubMed ID: 26219108
[No Abstract] [Full Text] [Related]
3. [Efficacy and safety of antivascular drugs after anti-EFGR: aflibercept after cetuximab, a clinical case].
Aroldi F; Zaniboni A
Recenti Prog Med; 2015 Dec; 106(12):653e-6e. PubMed ID: 26780078
[TBL] [Abstract][Full Text] [Related]
4. Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities.
Van Loon K; Venook AP
J Clin Oncol; 2014 Apr; 32(10):991-6. PubMed ID: 24516031
[No Abstract] [Full Text] [Related]
5. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
6. [A case of ascending colon cancer with unresectable distant metastases treated by systemic chemotherapy].
Sugimoto K; Tashiro Y; Nagayasu K; Niwa K; Ono S; Ishiyama S; Hata M; Komiyama H; Takahashi M; Yaginuma Y; Kojima Y; Goto M; Tanaka M; Sengoku H; Okuzawa A; Tomiki Y; Sakamoto K
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1167-70. PubMed ID: 20567130
[TBL] [Abstract][Full Text] [Related]
7. [A case of colon cancer with multiple lung metastases responding completely to FOLFIRI and FOLFOX therapy].
Kume S; Takahashi M; Kubota T; Hirata T; Torigoe Y; Ikeda O; Goto Y
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1809-12. PubMed ID: 20841953
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of CPT-11 combined 5-FU/CF (FOLFIRI) regimen on advanced colorectal cancer].
Luo HY; Li YH; Zhang L; Jiang WQ; Shi YX; Wang F; He YJ; Xu RH
Ai Zheng; 2007 Aug; 26(8):905-8. PubMed ID: 17697557
[TBL] [Abstract][Full Text] [Related]
9. [A case of colon cancer with multiple liver metastases responding ot S-1 as third-line treatment following FOLFIRI and FOLFOX].
Miyahira T; Teruya N; Matsuura F; Murayama S; Aka H; Teruya J; Hanashiro N; Nishihara M; Okushima N; Toda Y; Kiyuna M
Gan To Kagaku Ryoho; 2010 Feb; 37(2):331-4. PubMed ID: 20210032
[TBL] [Abstract][Full Text] [Related]
10. [A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy].
Yoshida R; Matsuura T; Hijikawa K; Yanagida H; Kitade H; Takada H; Kwon AH
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1575-7. PubMed ID: 23064076
[TBL] [Abstract][Full Text] [Related]
11. [A case of metastatic colon carcinoma in which a continuous intrahepatic artery-infusion of 5-FU leucovorin and cisplatin, and systemic chemotherapy with CPT-11 was very effective].
Ishikawa T; Nakamura M; Ohkuma K; Hisano C; Nakano S; Maruyama T; Kaji Y; Niho Y; Masumoto N
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1443-7. PubMed ID: 10969604
[TBL] [Abstract][Full Text] [Related]
12. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.
Gouveia HS; Lopes SO; Faria AL
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil plus leucovorin as adjuvant treatment of an experimental liver tumor in rats.
Carlsson G; Gustavsson BG; Spears CP; Hafström LO
Anticancer Res; 1990; 10(3):813-6. PubMed ID: 2369095
[TBL] [Abstract][Full Text] [Related]
14. Primary Adenocarcinoma with Focal Choriocarcinomatous Differentiation in the Sigmoid Colon.
Oh SK; Kim HW; Kang DH; Choi CW; Choi YY; Lim HK; Goo JJ; Choi SY
Korean J Gastroenterol; 2015 Nov; 66(5):291-6. PubMed ID: 26586354
[TBL] [Abstract][Full Text] [Related]
15. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
16. Panitumumab in metastatic colorectal cancer.
Wisinski KB; Mulcahy MF; Benson AB
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):10-1. PubMed ID: 17491586
[No Abstract] [Full Text] [Related]
17. The clinical efficacy of FOLFIRI and bevacizumab in combination as first-line therapy of metastatic colorectal cancer.
Grothey E; Chu E
Clin Colorectal Cancer; 2007 Sep; 6(9):621-4. PubMed ID: 17945033
[No Abstract] [Full Text] [Related]
18. [Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11].
Mazaki T; Mado K; Manmoto J; Okame H; Ishii Y; Suzuki K; Masuda H; Takayama T
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1583-6. PubMed ID: 18799916
[TBL] [Abstract][Full Text] [Related]
19. PET/triphasic contrast enhanced CT: Optimized protocol for the assessment of colorectal liver metastases.
Domínguez Ferreras E; García Vicente AM; Cano Cano JM; Molino Trinidad C; Soriano Castrejón AM; Espinosa Arrainz J
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):336-7. PubMed ID: 23583267
[No Abstract] [Full Text] [Related]
20. Dual deficiency of DPD and UGT1A1 in a case of colon cancer.
Rawlley B; Diab O; Al-Rajabi R; Carroll E; Melancon T; Kasi A
Pharmacogenomics; 2020 Dec; 21(18):1265-1269. PubMed ID: 33203301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
